Comparative Trial of Botulinum Toxin Type A and Methylprednisolone for The Treatment of Piriformis Syndrome

Iran University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新: 2020年2月24日

试验速览

暂无简介。

•The patients age : 20 years or older
•Screening of patients for clinically significant Lumbar disk herniation or Lumbosacral radiculopathy by Magnetic Resonance Imaging
•Trigger point and tenderness in their Gluteal area
•Pain in their buttocks radiating toward their thigh or lower limb and increasing with prolonged sitting and walking and during bending
•Increased pain through passive forced hip flexion, adduction, and internal rotation (FAIR position), and pain when the leg was flexed at the knee and the hip was passively and medially rotated (Freiberg test)
•Having pain for more than 3 months despite the conservative treatment and those whose individual minimum pain severity scores will be greater than 5 on a 10-point numeric rating scale (VAS criteria)

•Known allergy or sensitivity to botulinum toxin type A
•Previous use of botulinum toxin type A or B
•Current or planned pregnancy
•Disorders affecting the Neuromuscular junction or Motor neuron disease,Neurologic deficits found during Electromyelography
•Administration of Amino- Glycosides or other drugs that interfere with Neuromuscular transmission
•Previous Micro- surgery or Macro-surgery for disc disease, and any Epidural block within 7 weeks of enrollment

发起方